Cargando…
Anticoagulation Therapy After Biologic Aortic Valve Replacement
Objectives: Thromboembolism prophylaxis after biologic aortic valve replacement (BAVR) is recommended for 3 months postoperatively. We examined the continuation of oral anticoagulation (OAC) treatment and its effect on the long-term prognosis after BAVR. Methods: We used nation-wide register data fr...
Autores principales: | Myllykangas, Monna E., Kiviniemi, Tuomas O., Gunn, Jarmo M., Salomaa, Veikko V., Pietilä, Arto, Niiranen, Teemu J., Aittokallio, Jenni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256261/ https://www.ncbi.nlm.nih.gov/pubmed/34235192 http://dx.doi.org/10.3389/fcvm.2021.698784 |
Ejemplares similares
-
Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients
por: Lehto, Hanna-Riikka, et al.
Publicado: (2021) -
Sex differences in coronary artery bypass grafting-related morbidity and mortality
por: Nurkkala, Jouko, et al.
Publicado: (2022) -
Integrated Aortic-Valve-And-Ascending-Aortic Replacement vs. Partial Replacement in Bicuspid Aortic Valve-Related Aortopathy
por: Chen, Mi, et al.
Publicado: (2021) -
Patient-Tailored Aortic Valve Replacement
por: De Backer, Ole, et al.
Publicado: (2021) -
Hemodynamic Modeling of Biological Aortic Valve Replacement Using Preoperative Data Only
por: Hellmeier, Florian, et al.
Publicado: (2021)